When rogue brokers switch people’s ACA policies, tax surprises can follow

FHS
April 15, 2024
10:58 am

Tax season is never fun. But some tax filers this year face an added complication: Their returns are being rejected because they failed to provide information about Affordable Care Act coverage they didn’t even know they had.

Benralizumab Matches Mepolizumab for Rare Vasculitis

WASHINGTON — Treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA), the randomized MANDARA trial showed.

February 24, 2024

Exploring Japanese medicine: Longevity, lifestyle, and emerging health priorities

Investigating Japanese longevity reveals the impact of lifestyle medicine and government strategies on health, offering lessons for global wellness initiatives.

September 16, 2024

Is pharma still fearful of the Inflation Reduction Act?

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good summer morning! Today,

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.